Zentalis Pharmaceuticals, Inc. (ZNTL) Total liabilities 2022–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) total liabilities at each fiscal year-end, per SEC filings.
$72.8MFY2025 · since FY2022: $105.3M → $72.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $72.8M | -21.9% |
| FY2024 | $93.2M | -18.5% |
| FY2023 | $114.3M | +8.6% |
| FY2022 | $105.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice